Results 241 to 250 of about 781,057 (345)

Proliferative Diabetic Retinopathy in Young-Onset Type 1 Diabetes in Croatia: Risk Factors and a Predictive Economic Model for National Screening [PDF]

Ivan Borjan, Ivna Pleština-Borjan, Ljubo Znaor, Maja Pavić, Tatjana Josifova, Irena Marković, Beáta Éva Petrovski, Goran Petrovski   +7 more
openalex   +1 more source

Association between glucagon‐like peptide‐1 receptor agonists and risk of dementia in older adults with type 2 diabetes: A target trial emulation

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Type 2 diabetes (T2D) is associated with increased dementia risk, but comparative data across newer glucose‐lowering therapies remain limited. We examined whether the initiation of GLP‐1 receptor agonists (GLP‐1 RAs) was associated with incident dementia compared with DPP4 inhibitors (DPP4is) and SGLT2 inhibitors (SGLT2is) in older adults ...
Ting Zhou, Huilin Tang, Bingyu Zhang, Dazheng Zhang, Yiwen Lu, Lu Li, Jiajie Chen, Yong Chen, David A. Asch, Yong Chen   +9 more
wiley   +1 more source

Comparison of Visual Acuity in Macular Degeneration Patients Measured with Snellen and Early Treatment Diabetic Retinopathy Study Charts

, 2007
Iryna Falkenstein, Denine E. Cochran, Stanley P. Azen, Laurie Dustin, Ajay M. Tammewar, Igor Kozak, William R. Freeman   +6 more
openalex   +2 more sources

Literature‐informed ensemble machine learning for three‐year diabetic kidney disease risk prediction in type 2 diabetes: Development, validation, and deployment of the PSMMC NephraRisk model

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Introduction Diabetic kidney disease (DKD) and diabetic nephropathy (DN) affect around 40% of diabetic patients but lack accurate risk prediction tools that include social determinants and demographic complexity. We developed and validated an ensemble machine learning model for three‐year DKD/DN risk prediction with deployment readiness ...
Ayla M. Tourkmani, Turki J. Al‐Harbi, Ahmad Abdullah Alghamdi, Ibrahim M. Youzghadli, Faris Saad Alosaimi, Ahmed Y. Azzam   +5 more
wiley   +1 more source

Role of Trace Elements in Diabetic Retinopathy: A Systematic Review. [PDF]

Cureus
Gopal N, Telgote D, Manir MZ, S A, Haldar U, Amle D.   +5 more
europepmc   +1 more source

Asymmetric diabetic retinopathy

Journal of Diabetes, 2010
Nabil, El Hindy, Jong Min, Ong
openaire   +2 more sources

Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim This study evaluated the efficacy and safety of empagliflozin 10 and 25 mg compared to placebo as add‐on treatment for people with type 2 diabetes mellitus (T2DM) uncontrolled after ≥8 weeks of treatment with metformin and sitagliptin. Materials and Methods A randomised, double‐blind, multicentre, therapeutic confirmatory, phase 3 clinical
Seung‐Hwan Lee, Kyung Ah Han, Eun‐Gyoung Hong, Jun Goo Kang, Choon Hee Chung, Jong Chul Won, Eon Ju Jeon, Jung‐Hwan Cho, Ho Chan Cho, Sin Gon Kim, Eun Seok Kang, So Hun Kim, Hae Jin Kim, In‐Kyung Jeong, Sung Wan Chun, Young Min Cho   +15 more
wiley   +1 more source

Determinants of diabetic retinopathy among adult and elderly individuals with diabetes. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Addis WD, Admas WT, Ayalew AA, Yirdaw G, Ayele WM, Ahmed AF, Kassa AA, Tsega TD, Shimels T, Anteneh RM, Temesgen A, Bayeh GM, Yeshiwas AG, Mekonen H, Mekonnen BA, Alemayehu MA, Tsega SS, Yigzaw ZA, Ejigu AG, Yenew C, Malkamu B, Teym A, Sharew KE, Adane D, Ayalew CA, Yemata GA.   +25 more
europepmc   +1 more source

Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy.

, 2015
Yan Gao, Yan Zhang, Yusha Ru, Xiaowu Wang, Jizhong Yang, Chunhui Li, Hongxing Wang, Xiaorong Li, Bing Li   +8 more
openalex   +2 more sources